1. Home
  2. WTS vs CYTK Comparison

WTS vs CYTK Comparison

Compare WTS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTS

Watts Water Technologies Inc.

N/A

Current Price

$362.46

Market Cap

12.1B

Sector

Industrials

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$61.42

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WTS
CYTK
Founded
1874
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
10.7B
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
WTS
CYTK
Price
$362.46
$61.42
Analyst Decision
Hold
Strong Buy
Analyst Count
10
23
Target Price
★ $403.71
$109.20
AVG Volume (30 Days)
194.3K
★ 1.8M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
★ 0.69%
N/A
EPS Growth
★ 17.03
N/A
EPS
★ 6.50
N/A
Revenue
★ $2,438,500,000.00
$13,368,000.00
Revenue This Year
$15.98
$77.58
Revenue Next Year
$5.73
$174.14
P/E Ratio
$56.40
★ N/A
Revenue Growth
★ 8.27
N/A
52 Week Low
$260.00
$58.05
52 Week High
$394.54
$88.31

Technical Indicators

Market Signals
Indicator
WTS
CYTK
Relative Strength Index (RSI) 53.79 36.41
Support Level $337.32 $59.21
Resistance Level $369.97 $67.65
Average True Range (ATR) 7.88 1.91
MACD 1.13 0.19
Stochastic Oscillator 70.15 19.97

Price Performance

Historical Comparison
WTS
CYTK

About WTS Watts Water Technologies Inc.

Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: